Clinical Trial Update: HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia [Phase 1, Phase 2]

View source ↗

Summary

HORNBILL tested different doses of BI 764524 in patients with diabetic retinopathy and diabetic macular ischemia; the Phase 1/2 study is completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Ischemia
• Diabetic Retinopathy

Drugs mentioned

• BI 764524

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetic Retinopathy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-22